OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 73 citing articles:

Reprogramming endothelial cells to empower cancer immunotherapy
Abigail H. Cleveland, Yi Fan
Trends in Molecular Medicine (2023) Vol. 30, Iss. 2, pp. 126-135
Closed Access | Times Cited: 9

The effect of immune cell‐derived exosomes in the cardiac tissue repair after myocardial infarction: Molecular mechanisms and pre‐clinical evidence
Heling Wen, Lei Peng, Yu Chen
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 14, pp. 6500-6510
Open Access | Times Cited: 23

LncRNA PVT1 facilitates DLBCL development via miR-34b-5p/Foxp1 pathway
Tao Shi, Yu Chen, Min Hu, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 3, pp. 951-963
Closed Access | Times Cited: 14

Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction
Yong Wang, Juan Zhang, Zhen Wang, et al.
Heart Failure Reviews (2022) Vol. 28, Iss. 1, pp. 169-178
Open Access | Times Cited: 14

Big Endothelin-1 as a Predictor of Reverse Remodeling and Prognosis in Dilated Cardiomyopathy
Jiayu Feng, Lin Liang, Yuyi Chen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1363-1363
Open Access | Times Cited: 8

The role of endothelial cell in cardiac hypertrophy: Focusing on angiogenesis and intercellular crosstalk
Xing Yang, Kun Cheng, Lu-Yun Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114799-114799
Open Access | Times Cited: 8

Role of IgE-FcεR1 in Pathological Cardiac Remodeling and Dysfunction
Hongmei Zhao, Hongqin Yang, Chi Geng, et al.
Circulation (2020) Vol. 143, Iss. 10, pp. 1014-1030
Open Access | Times Cited: 21

Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis
Xiaomin Luo, Cen Yan, Yingmei Feng
Advanced Drug Delivery Reviews (2021) Vol. 172, pp. 234-248
Open Access | Times Cited: 20

GPCRs and fibroblast heterogeneity in fibroblast‐associated diseases
Nidhi V. Dwivedi, Souvik Datta, Karim El‐Kersh, et al.
The FASEB Journal (2023) Vol. 37, Iss. 8
Open Access | Times Cited: 7

Demonstration of the Protective Effect of Vinpocetine in Diabetic Cardiomyopathy
Demet Erciyes, Ejder Saylav Bora, Mustafa Agâh Tekindal, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4637-4637
Open Access | Times Cited: 2

Epigenetic regulation of mitochondrial fission and cardiac fibrosis via sFRP3 promoter methylation
S. W. Jiang, Ze‐Yu Zhou, Bin Tu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2

Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases
Xinming Liu, Sheng-Li Du, Ran Miao, et al.
Heart Failure Reviews (2020) Vol. 27, Iss. 1, pp. 345-355
Closed Access | Times Cited: 19

Fraxinellone alleviates colitis-related intestinal fibrosis by blocking the circuit between PD-1+ Th17 cells and fibroblasts
Y. C. Xu, Chang Zheng, Ping Jiang, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112298-112298
Closed Access | Times Cited: 2

Increase in urine albumin-to-creatinine ratio as one of the earliest markers of renal damage in patients with hypertension and type 2 diabetes mellitus
S.M. Koval, Л.А. Рєзнік, T. Starchenko, et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2024) Vol. 20, Iss. 4, pp. 272-277
Open Access | Times Cited: 2

LncRNA ROR promotes NLRP3-mediated cardiomyocyte pyroptosis by upregulating FOXP1 via interactions with PTBP1
Min Zeng, Shijiang Yi, Yunbin Xiao, et al.
Cytokine (2022) Vol. 152, pp. 155812-155812
Closed Access | Times Cited: 10

Pentraxin 3 depletion (PTX3 KD) inhibited myocardial fibrosis in heart failure after myocardial infarction
Yufang Xu, Yiting Hu, Yanping Geng, et al.
Aging (2022) Vol. 14, Iss. 9, pp. 4036-4049
Open Access | Times Cited: 10

Anti-Arrhythmic Effects of Sodium-Glucose Co-Transporter 2 Inhibitors
Yuling Jing, Ruixue Yang, Wen Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10

Endothelial Foxp1 Regulates Neointimal Hyperplasia Via Matrix Metalloproteinase‐9/Cyclin Dependent Kinase Inhibitor 1B Signal Pathway
Xiaoli Chen, Jianfei Xu, Wenzhen Bao, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 15
Open Access | Times Cited: 10

Lymphatic endothelial sphingosine 1-phosphate receptor 1 enhances macrophage clearance via lymphatic system following myocardial infarction
Qinyu Li, Caixia Zhou, Kang Zhao, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 9

Transcription factor Foxp1 stimulates angiogenesis in adult rats after myocardial infarction
Dinghui Wang, Bin Liu, Tianhua Xiong, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 8

The Impact of Inflammatory Immune Reactions of the Vascular Niche on Organ Fibrosis
Hongyan Zhou, Hua Sui, Yang-Jianing Zhao, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 11

FOXP1: A Gatekeeper of Endothelial Cell Inflammation
Jenny E. Kanter
Circulation Research (2019) Vol. 125, Iss. 6, pp. 606-608
Open Access | Times Cited: 10

Scroll to top